Metabolic engineering strategies for enhanced shikimate biosynthesis: current scenario and future developments
Shikimic acid is an important intermediate for the manufacture of the antiviral drug oseltamivir (Tamiflu®) and many other pharmaceutical compounds. Much of its existing supply is obtained from the seeds of Chinese star anise (Illicium verum). Nevertheless, plants cannot supply a stable source of affordable shikimate along with laborious and cost-expensive extraction and purification process. Microbial biosynthesis of shikimate through metabolic engineering and synthetic biology approaches represents a sustainable, cost-efficient, and environmentally friendly route than plant-based methods. Metabolic engineering allows elevated shikimate production titer by inactivating the competing pathways, increasing intracellular level of key precursors, and overexpressing rate-limiting enzymes. The development of synthetic and systems biology-based novel technologies have revealed a new roadmap for the construction of high shikimate-producing strains. This review elaborates the enhanced biosynthesis of shikimate by utilizing an array of traditional metabolic engineering along with novel advanced technologies. The first part of the review is focused on the mechanistic pathway for shikimate production, use of recombinant and engineered strains, improving metabolic flux through the shikimate pathway, chemically inducible chromosomal evolution, and bioprocess engineering strategies. The second part discusses a variety of industrially pertinent compounds derived from shikimate with special reference to aromatic amino acids and phenazine compound, and main engineering strategies for their production in diverse bacterial strains. Towards the end, the work is wrapped up with concluding remarks and future considerations.
KeywordsShikimic acid Metabolic engineering Systems biotechnology Bioprocess engineering Shikimate-derived compounds Biological functionalities
This work was supported by the National Natural Science Foundation of China (No. 31670033).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Bilal M, Yue S, Hu H, Wang W, Zhang X (2018b) Adsorption/desorption characteristics, separation and purification of phenazine-1-carboxylic acid from fermentation extract by macroporous adsorbing resins. J Chem Technol Biotechnol. https://doi.org/10.1002/jctb.5673
- Blanco B, Prado V, Lence E, Otero JM, Garcia-Doval C, van Raaij MJ, Llamas-Saiz AL, Lamb H, Hawkins AR, Gonzalez-Bello C (2013) Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover. J Am Chem Soc 135(33):12366–12376PubMedCrossRefGoogle Scholar
- Chin-A-Woeng TFC, van den Broek D, de Voer G, van der Drift KM, Tuinman S, Thomas-Oats JE, Lugtenberg BJJ, Bloemburg GV (2001) Phenazine-1-carboxamide production in the biocontrol strain Pseudomonas chlororaphis PCL1391 is regulated by multiple factors secreted in the growth medium. Mol Plant-Microbe Interact 14:969–979PubMedCrossRefGoogle Scholar
- Dasgupta D, Kumar A, Mukhopadhyay B, Sengupta TK (2015) Isolation of phenazine 1,6-di-carboxylic acid from Pseudomonas aeruginosa strain HRW.1-S3 and its role in biofilm-mediated crude oil degradation and cytotoxicity against bacterial and cancer cells. Appl Microbiol Biotechnol 99:8653–8665PubMedCrossRefGoogle Scholar
- Diaz-Quiroz DC, Cardona-Felix CS, Viveros-Ceballos JL, Reyes-Gonzalez MA, Bolivar F, Ordonez M, Escalante A (2018) Synthesis, biological activity and molecular modelling studies of shikimic acid derivatives as inhibitors of the shikimate dehydrogenase enzyme of Escherichia coli. J Enzyme Inhib Med Chem 33(1):397–404PubMedPubMedCentralCrossRefGoogle Scholar
- Escalante A, Calderon R, Valdivia A, de Anda R, Hernandez G, Ramirez OT, Gosset G, Bolivar F (2010) Metabolic engineering for the production of shikimic acid in an evolved Escherichia coli strain lacking the phosphoenolpyruvate: carbohydrate phosphotransferase system. Microb Cell Factories 9:21CrossRefGoogle Scholar
- Farrell N, Roberts JD, Hacker MP (1991) Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato) platinum(II). Evidence for a novel rearrangement involving platinum-carbon bond formation. J Inorg Biochem 42(4):237–246PubMedCrossRefGoogle Scholar
- Iomantas YAV, Abalakina EG, Polanuer BM, Yampolskaya TA, Bachina TA, Kozlov YI (2002) Method for producing shikimic acid, USGoogle Scholar
- Iyer S, Pejakala V, Karabasanagouda V, Wagle S, Balaya L, Kanaka M, Hiremath M (2007) Method for obtaining shikimic acid, woGoogle Scholar
- Keseler IM, Mackie A, Peralta-Gil M, Santos-Zavaleta A, Gama-Castro S, Bonavides-Martinez C, Fulcher C, Huerta AM, Kothari A, Krummenacker M, Latendresse M, Muniz-Rascado L, Ong Q, Paley S, Schroder I, Shearer AG, Subhraveti P, Travers M, Weerasinghe D, Weiss V, Collado-Vides J, Gunsalus RP, Paulsen I, Karp PD (2013) EcoCyc: fusing model organism databases with systems biology. Nucleic Acids Res 41:D605–D612PubMedCrossRefGoogle Scholar
- Kim TH, Namgoong S, Kwak JH, Lee SY, Lee HS (2000) Effects of tktA, aroF FBR, and aroL expression in the tryptophan-producing Escherichia coli. J Microbiol Biotechnol 10:789–796Google Scholar
- Li Z, Ji X, Kan S, Qiao H, Jian M, Lu D, Wang J, Huang H, Jia H, Ouyuang P, Ying H (2010) Past, present and future industrial biotechnology in China. In: Tsao GT, Ouyang P, Berlin CJ (eds) Biotechnol China II Chem Energy Environ. Springer, Heidelberg, pp 1–42Google Scholar
- Liu JZ, Huang MT, Cui YY, Chen YY (2012) A series of expression plasmids for chromosomal integration and evolution. Chinese patent 201210060042.5Google Scholar
- Ma Y, Sun JN, Xu QP, Guo YJ (2000) Inhibitory effects of shikimic acid on platelet aggragation and blood coagulation. Acta Pharmacol Sin 5(5):600–612Google Scholar
- Martinez JA, Bolivar F, Escalante A (2015) Shikimic acid production in Escherichia coli: from classical metabolic engineering strategies to omics applied to improve its production. Front Bioeng Biotechnol 3:45Google Scholar
- Rodriguez A, Martínez JA, Báez-Viveros JL, Flores N, Hernández-Chávez G, Ramírez OT, Gosset G, Bolivar F (2013) Constitutive expression of selected genes from the pentose phosphate and aromatic pathways increases the shikimic acid yield in high-glucose batch cultures of an Escherichia coli strain lacking PTS and pykF. Microb Cell Factories 12:86CrossRefGoogle Scholar
- Rodriguez A, Martinez JA, Millard P, Gosset G, Portais JC, Letisse F, Bolivar F (2017) Plasmid-encoded biosynthetic genes alleviate metabolic disadvantages while increasing glucose conversion to shikimate in an engineered Escherichia coli strain. Biotechnol Bioeng 114:1319–1330PubMedCrossRefGoogle Scholar
- Shirai M, Miyata R, Sasaki S, Sakamoto K, Yahanda S, Shibayama K, Yonehara T, Ogawa K (2001) Microorganism belonging to the genus citrobacter and process for producing shikimic acid. European Patent, 1092766Google Scholar
- Sprenger G (2007a) Aromatic amino acids. In Amin Acid Biosynth - Pathways, Regul Metab Eng. Wendisch VF (ed) Berlin, Heidelberg: Springer, p 418 [Microbiology Monographs, vol. 5]Google Scholar
- St-Onge R, Gadkar VJ, Arseneault T, Goyer C, Filion M (2011) The ability of Pseudomonas sp. LBUM 223 to produce phenazine-1-carboxylic acid affects the growth of Streptomyces scabies, the expression of thaxtomin biosynthesis genes and the biological control potential against common scab of potato. FEMS Microbiol Ecol 75:173–183PubMedCrossRefGoogle Scholar
- Tissier A, Ziegler J, Vogt T (2014) Specialized plant metabolites: diversity and biosynthesis. Wiley-VCH Verlag GmbH & Co KGaA. pp 14–37. https://doi.org/10.1002/9783527686063.ch2
- Wojtowicz W, Piotr M (2016) Metabolomics and fluxomics in biotechnology: current trends. J Biotechnol Comput Biol Bionanotechnol 97(2):137–144Google Scholar